Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGF β) provides significant antitumor efficacy in immune checkpoint resistant models

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - October 2, 2022 Category: Cancer & Oncology Authors: S. Elizabeth Franks Kellsye P. Fabian Ginette Santiago-S ánchez Benjamin Wolfson James W. Hodge Source Type: research